Vulvar Lymphadenopathy – A Complete Patient Guide
Overview
Vulvar lymphadenopathy refers to the enlargement or abnormal condition of the lymph nodes that drain the vulva, the external female genitalia that includes the labia majora, labia minora, clitoral hood, and the surrounding skin. These nodes are primarily located in the superficial inguinal region (the groin) and, less commonly, in the deep inguinal and femoral chains.
While any person with a vulva can develop lymph node swelling, it is most frequently seen in:
- Women of reproductive age (15‑45 years) because of higher rates of sexually transmitted infections (STIs) and reproductive‑tract pathology.
- Post‑menopausal women with a history of vulvar cancer or chronic inflammatory skin conditions.
- Individuals with compromised immune systems (e.g., HIV, organ‑transplant recipients).
Exact prevalence data are limited because vulvar lymphadenopathy is usually reported as a component of underlying diseases (e.g., vulvar cancer, HPV infection). However, epidemiological studies of inguinal lymphadenopathy in women range from **2‑5 %** of all emergency‑department visits for groin pain to **up to 15 %** in HIV‑positive cohorts [CDC].
Symptoms
Symptoms can be subtle or conspicuous, depending on the cause and the extent of node involvement.
Local Symptoms
- Palpable lump(s) in the groin – usually firm, sometimes tender.
- Pain or aching – may be constant or worsened by walking, sitting, or tight clothing.
- Swelling of the vulva – can be diffuse or limited to the labia.
- Redness or warmth over the affected area, suggesting inflammation.
- Skin changes – such as ulceration, fissuring, or a “pimple‑like” lesion on the vulva that may drain.
Systemic Symptoms
- Low‑grade fever (often <38 °C/100.4 °F) especially when infection is the cause.
- Unexplained weight loss or night sweats (red flags for malignancy).
- General fatigue or malaise.
Symptoms Specific to Certain Causes
- Sexually transmitted infection (e.g., chancroid, herpes) – painful vesicles or ulcerations on the vulva.
- Vulvar cancer – persistent ulcer, a lump that does not heal, or foul‑smelling discharge.
- Skin conditions (lichen sclerosus, psoriasis) – itching, burning, white‑patches.
Causes and Risk Factors
Vulvar lymphadenopathy is not a disease itself; it is a sign that a process is affecting the vulva or the lymphatic drainage pathways.
Infectious Causes
- Sexually transmitted infections – Chlamydia trachomatis, Neisseria gonorrhoeae, Herpes simplex virus, Human papillomavirus (HPV), and Treponema pallidum (syphilis).
- Bacterial cellulitis or abscess – often Staphylococcus or Streptococcus species.
- Fungal infections – Candida vulvovaginitis can trigger reactive nodes.
- Mycobacterial infections – atypical mycobacteria (e.g., Mycobacterium avium) in immunocompromised patients.
Malignancy
- Vulvar squamous cell carcinoma – the most common vulvar cancer; spreads first to the inguinal nodes.
- Melanoma of the vulva – aggressive with early nodal involvement.
- Metastatic disease – from cervical, anal, or colorectal cancers.
Inflammatory / Autoimmune Conditions
- Lichen sclerosus, lichen planus, and chronic dermatitis.
- Dermatomyositis or systemic lupus erythematosus (SLE) with cutaneous involvement.
Other Risk Factors
- Multiple sexual partners or unprotected intercourse.
- History of prior vulvar surgery or radiation therapy.
- Immunosuppression (HIV, long‑term corticosteroids, chemotherapy).
- Obesity – excess adipose tissue can impede lymphatic flow.
- Chronic lymphedema from previous node dissection or filariasis.
Diagnosis
Because the underlying cause dictates treatment, a systematic diagnostic approach is essential.
Clinical Evaluation
- History – sexual activity, recent infections, prior cancers, systemic symptoms.
- Physical examination – inspection of the vulva, palpation of inguinal nodes (size, consistency, tenderness, fixation).
Imaging Studies
- Ultrasound – first‑line to assess node size, vascularity, and presence of an abscess.
- Magnetic resonance imaging (MRI) – superior soft‑tissue detail for suspected malignancy.
- Computed tomography (CT) or PET‑CT – for staging cancer or evaluating deep pelvic nodes.
Laboratory Tests
- Complete blood count (CBC) & inflammatory markers (CRP, ESR).
- Serologic testing for HIV, syphilis, and hepatitis.
- Swabs or scrapings from vulvar lesions for Gram stain, culture, PCR for HPV, HSV, or chlamydia.
Pathologic Confirmation
- Fine‑needle aspiration (FNA) – cytology of the node to differentiate reactive vs. malignant cells.
- Core needle or excisional biopsy – provides tissue architecture, crucial for cancer staging.
- Sentinel‑node mapping – performed during vulvar cancer surgery to identify the first draining node.
Diagnostic Criteria (Simplified)
| Finding | Interpretation |
|---|---|
| Node < 1 cm, mobile, non‑tender | Likely reactive |
| Node ≥ 1 cm, firm, fixed, or painful | Consider infection or malignancy |
| Associated ulcer, discharge, or systemic signs | Prompt further microbiologic/oncologic work‑up |
Treatment Options
Treatment is tailored to the underlying etiology and the severity of node involvement.
Infectious Causes
- Antibiotics – e.g., azithromycin 1 g single dose for chlamydia, doxycycline 100 mg BID for 7 days for chancroid. Broad‑spectrum coverage (clindamycin + gentamicin) for cellulitis.
- Antivirals – Acyclovir 400 mg TID for HSV lesions; adherence to a 7‑10 day course.
- Antifungals – Fluconazole 150 mg PO single dose for candidiasis.
- Drainage – Incision and drainage of abscesses under aseptic technique.
Malignant Causes
- Surgery – Wide local excision of the vulvar lesion plus inguinal lymphadenectomy (sentinel‑node biopsy when appropriate). Lymph‑sparing techniques reduce postoperative lymphedema [Cleveland Clinic].
- Radiation therapy – Adjuvant external‑beam radiation for positive nodes or unresectable disease.
- Chemotherapy / Immunotherapy – Cisplatin‑based regimens, pembrolizumab for PD‑L1‑positive vulvar SCC.
- Targeted therapy – EGFR inhibitors in selected cases.
Inflammatory / Autoimmune Conditions
- High‑potency topical steroids (clobetasol propionate 0.05 % ointment) for lichen sclerosus; taper based on response.
- Systemic agents (hydroxychloroquine, methotrexate) for refractory disease under rheumatology supervision.
Supportive / Lifestyle Measures
- Pain control – NSAIDs (ibuprofen 400‑600 mg q6‑8h) or acetaminophen.
- Compression garments to reduce swelling after lymph node surgery.
- Skin‑care regimen – gentle, fragrance‑free cleansers, moisturizers, and avoidance of irritants.
Living with Vulvar Lymphadenopathy
Even after the primary cause is managed, many women experience lingering concerns. The following tips can improve daily comfort and quality of life.
Hygiene & Skin Care
- Wash with warm water and a mild, unscented cleanser; pat dry instead of rubbing.
- Apply a barrier cream (e.g., zinc oxide) after bathing if skin is irritated.
- Avoid tight underwear; choose breathable cotton fabrics.
Physical Activity
- Gentle walking promotes lymphatic flow; aim for 20‑30 minutes most days.
- Consider a certified lymphedema therapist for “manual lymphatic drainage” if nodes were removed.
Pain & Comfort
- Use a cold pack (wrapped in a towel) for 10‑15 minutes to ease swelling.
- Maintain a balanced diet rich in protein and vitamin C to support healing.
Emotional Well‑Being
- Join support groups (e.g., the International Vulvar Cancer Alliance) for shared experiences.
- Seek counseling if anxiety about recurrence or body image becomes overwhelming.
Follow‑Up Schedule
After treatment, most clinicians recommend:
- Every 3‑4 months for the first year.
- Every 6 months for years 2‑3.
- Annual visits thereafter, unless new symptoms develop.
Prevention
Because many causes are modifiable, preventive measures can markedly lower risk.
- Safe sexual practices – Consistent condom use, limiting partners, and regular STI screening (at least annually for sexually active adults).
- HPV vaccination – Recommended up to age 45; reduces incidence of HPV‑related vulvar cancers [CDC].
- Smoking cessation – Smoking doubles the risk of vulvar SCC.
- Weight management – BMI < 30 kg/m² lessens pressure on lymphatic channels.
- Prompt treatment of genital infections – Early antibiotic/antiviral therapy prevents spread to lymph nodes.
- Skin care vigilance – Treat chronic dermatitis early; avoid harsh soaps or irritants.
Complications
If the underlying condition is not addressed, several complications may arise:
- Chronic lymphedema – Persistent swelling, skin thickening, and risk of cellulitis.
- Secondary infection – Lymph node necrosis can become a source of systemic infection (sepsis).
- Painful scar tissue – Can limit mobility and affect sexual function.
- Progression to invasive cancer – Particularly when atypical cells are present in the nodes.
- Psychological distress – Anxiety, depression, and sexual dysfunction are common in chronic vulvar disease.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden, severe groin or vulvar pain that worsens rapidly.
- High fever (> 39 °C / 102 °F) with chills.
- Rapidly expanding, red, and warm swelling suggesting an abscess.
- Signs of sepsis: rapid heartbeat, dizziness, confusion, or a drop in blood pressure.
- Uncontrolled bleeding from a vulvar lesion.
References:
- Mayo Clinic. “Vulvar cancer.” https://www.mayoclinic.org. Accessed June 2026.
- CDC. “Lymphadenopathy in HIV infection.” https://www.cdc.gov. 2023.
- National Institutes of Health. “Human papillomavirus (HPV) and cancers.” https://www.cancer.gov. Updated 2024.
- World Health Organization. “WHO guidelines on STI management.” 2022.
- Cleveland Clinic. “Inguinal lymph node dissection and lymphedema.” https://my.clevelandclinic.org. 2023.
- International Vulvar Cancer Alliance. “Patient resources.” https://www.ivca.org. 2025.